Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study

Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study

This study aimed to explore the existence of circulating tumor cells (CTCs) in patients with muscle-invasive bladder cancer (MIBC) and their predictive potential for response to neoadjuvant chemotherapy (NAC). From 33 blood samples of MIBC patients, CTCs were isolated by cell surface markers and enr...

Full description

Bibliographic Details
Main Authors:	Yu-Cing Jhuo, Tai-Lung Cha, Chien-Chang Kao, Yi-Ta Tsai, Sheng-Tang Wu, En Meng, Chih-Wei Tsao, Chin-Li Chen, Hui-Kung Ting, Guang-Huan Sun, Dah-Shyong Yu, Sun-Yran Chang, Ming-Hsin Yang
Format:	Article
Language:	English
Published:	MDPI AG 2023-03-01
Series:	Diagnostics
Subjects:	circulating tumor cells muscle-invasive bladder cancer neoadjuvant chemotherapy radical cystectomy urothelial carcinoma
Online Access:	https://www.mdpi.com/2075-4418/13/6/1032

Similar Items

Risk and predictors of patients receiving neoadjuvant chemotherapy followed by radical cystectomy or transurethral resection alone for muscle-invasive bladder cancer: A single-institute experience
by: Pei-Jhang Chiang, et al.
Published: (2022-01-01)

Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer
by: Bryce Baird, et al.
Published: (2023-08-01)

Role of B7‐H3 in predicting response to neoadjuvant chemotherapy in muscle‐invasive bladder cancer
by: Ekamjit S. Deol, et al.
Published: (2024-11-01)

Outcomes and prognostic factors of simple partial cystectomy for localized bladder urothelial cell carcinoma
by: I-Hung Shao, et al.
Published: (2016-04-01)

Effects of Neoadjuvant Chemotherapy on Rates of Depression in Muscle Invasive Bladder Cancer
by: Matthew DeSanto, et al.
Published: (2024-07-01)

Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients
by: Daniel Au, et al.
Published: (2021-07-01)

Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
by: Dellis A, et al.
Published: (2021-07-01)

Cystectomy vs. bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer: A tertiary medical center experience
by: Ibrahim El Halabi, et al.
Published: (2020-01-01)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
by: Arthur Peyrottes, et al.
Published: (2021-07-01)

BCG Induced Necrosis of the Entire Bladder Urothelium
by: Malte Krönig, et al.
Published: (2015-09-01)

Radical Cystectomy for Intradiverticular Bladder Carcinoma: A Case Report
by: Anil Kumar Sah, et al.
Published: (2021-10-01)

Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion
by: Ahmed Eldefrawy, et al.
Published: (2012-01-01)

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
by: Oktay Üçer
Published: (2016-04-01)

Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
by: Thanh-Tuan Nguyen, et al.
Published: (2018-09-01)

A brief review and case report of urothelial carcinoma and metachronous leiomyosarcoma of the bladder at the same anatomic region
by: Yajie Li, et al.
Published: (2022-01-01)

Urothelial carcinoma in a urinary bladder diverticulum: A case report and review of the literature
by: Andro Matković, MD, et al.
Published: (2023-03-01)

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
by: F. J. Hinsenveld, et al.
Published: (2021-10-01)

Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients
by: Homin Kang, et al.
Published: (2024-05-01)

Self-catheterization of urinary bladder complicated with extraperitoneal abscess that mimics an infected bladder diverticulum
by: Yu-Cing Juho, et al.
Published: (2014-12-01)

Real-world data on utilization of neoadjuvant chemotherapy for muscle invasive bladder cancer: impact on surgical complications and oncological efficacy
by: Hege S. Haugnes, et al.
Published: (2025-01-01)

Challenges and opportunities in the management of non-urothelial bladder cancers
by: Jacqueline T. Brown, et al.
Published: (2023-01-01)

Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology
by: Vahid Mehrnoush, et al.
Published: (2022-09-01)

Pathological response and survival outcomes after neoadjuvant chemotherapy with radical cystectomy in octogenarians for muscle-invasive bladder cancer: an observational database study
by: Arjun Pon Avudaiappan, et al.
Published: (2024-07-01)

Urothelial carcinoma of the bladder with cutaneous metastases after robot-assisted radical cystectomy. Case report
by: Shugo Yajima, et al.
Published: (2021-09-01)

Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients
by: Agus Rizal A. H. Hamid, et al.
Published: (2020-10-01)

Comparison of trimodality therapy and neoadjuvant chemotherapy combined with radical cystectomy for the survival of muscle-invasive bladder cancer: a population-based analysis
by: Yi-Xin Zhou, et al.
Published: (2023-10-01)

Comparative analysis between radical cystectomy and trimodality therapy for clinical Stage II Bladder Cancer: Experience from a tertiary referral center
by: Jian-Hua Hong, et al.
Published: (2018-01-01)

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival
by: Gang Li, et al.
Published: (2017-08-01)

Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy
by: Qian H, et al.
Published: (2022-04-01)

Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion following Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer: An Initial Experience
by: Tünkut Doğanca, et al.
Published: (2024-06-01)

Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
by: Harriet Rydell, et al.
Published: (2022-08-01)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: No
by: Timur Mitin

The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study
by: Wasilijiang Wahafu, et al.
Published: (2019-11-01)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes
by: Leonardo L. Monteiro, et al.

Survival after radiotherapy versus radical cystectomy for primary muscle‐invasive bladder cancer: A Swedish nationwide population‐based cohort study
by: Christel Häggström, et al.
Published: (2019-05-01)

Case Report: A Rare Case with Cutaneous Metastasis of Bladder Urothelial Carcinoma
by: Min-Jui Wu, et al.
Published: (2024-04-01)

Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder
by: Wempy Supit, et al.
Published: (2014-10-01)

Evaluation of short-term outcomes of neoadjuvant chemotherapy followed by radical cystectomy in muscle-invasive bladder cancer: a single Egyptian institution experience
by: Ibrahim Abdelrahman, et al.
Published: (2023-05-01)

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
by: Filipe LF. Carvalho, et al.
Published: (2020-07-01)

Editorial: Radical cystectomy in bladder cancer patients
by: Vadim S. Koshkin, et al.
Published: (2022-12-01)